Turin confirms itself as one of the leading centers in Italy in the adoption of advanced technologies in the medical field. Recently, at the Cardiology Department of the Mauriziano Hospital, the first surgery in Italy was performed with the new Evolut FX+ transcatheter aortic valve, a cutting-edge technology that improves maneuverability during implantation, reducing risks and optimizing surgery times. This innovation marks an important step in the use of MedTech solutions for the treatment of heart disease.

The Evolut FX+ valve represents a significant evolution in the industry, combining precision, safety and easy access to the coronary arteries, making procedures more effective and accessible to an increasingly wide range of patients, including the elderly or those with concomitant conditions.

The Mauriziano Hospital is an example of how Turin is leading innovation in the HealthTech sector, with a strong focus on minimally invasive solutions that improve the quality of care. The city is emerging as a hub of excellence for research and adoption of advanced medical technologies, helping to transform the healthcare landscape and improve access to effective and safe treatments.

Thanks to the adoption of cutting-edge MedTech and Biotech solutions, Turin is an example of how innovation can improve medicine, making treatments safer and more effective and preparing the city for an increasingly advanced digital health future.